Knight Therapeutics Inc (FRA:04K)
€ 3.42 -0.36 (-9.52%) Market Cap: 354.19 Mil Enterprise Value: 277.97 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 88/100

Knight Therapeutics Inc Annual Shareholders Meeting Transcript

May 10, 2023 / 01:00PM GMT
Release Date Price: €3.18 (+1.92%)
Operator

Hello, and welcome. You are joining Knight Therapeutics Annual General Meeting. Please note that today's meeting is being recorded. (Operator Instructions)

I would now like to turn today's meeting over to Jonathan Goodman, Chairman of the meeting. Please go ahead.

Jonathan Ross Goodman
Knight Therapeutics Inc. - Executive Chairman

Good morning. Welcome to Knight Therapeutics Annual Meeting of Shareholders. Once again, this year, we have chosen to hold the meeting via live audio webcast. My name is Jonathan Goodman, Executive Chairman of Knight Therapeutics, and I will chair today's meeting. Also with me on the call is Samira Sakhia, our President and Chief Executive Officer; and Bryan Kujawski, our External Counsel. Samira will act as Secretary of today's meeting. Steve Gilbert and Claire Girard of Computershare Investor Services will be acting as scrutineers for this meeting.

Our agenda today is straightforward. First, we will conduct the formal part of the meeting. Following the formal part of the meeting, Samira will make a few remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot